Vafseo trial stopped early after interim data shows fewer hospitalizations

Go back to Vafseo trial stopped early after interim data shows fewer hospitalizations
AKEBIA THERAPEUTICS (NASDAQ: AKBA) Delayed: 0.90 -0.02 (2.17%)
Previous Close $0.92    52 Week High $13.20 
Open $0.92    52 Week Low $7.00 
Day High $0.93    P/E N/A 
Day Low $0.89    EPS $0.00 
Volume 4,374,734